No Data
No Data
Express News | Genentech's Prasinezumab Phase IIb Study Misses Primary Endpoint But Shows Potential In Early Parkinson's Disease
Roche Says Parkinson's Disease Drug Missed Main Goal of Phase 2b Trial
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Roche Gets CE Marking for Mass Spectrometry Tech
Roche Transforms Mass Spectrometry Diagnostics With Launch of Cobas Mass Spec Solution
Novo's New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. -- Barrons.com
72464536 : I hope you’re right!!!!